BMRN vs NCNO · P/E 40, rev $1.76B vs rev $594.8M
Biomarin Pharmaceutical Inc (BMRN) versus nCino Inc (NCNO) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
nCino Inc (NCNO) is a software - application company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported NCNO revenue for 2026-01-31 was $594.8M. Net income was $5.2M. Revenue was up 10.0% from 2025-01-31 to 2026-01-31. NCNO currently screens at market cap $3.33B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. NCNO currently screens at market cap $3.33B.
Not investment advice. Open the BMRN and NCNO stock pages for the full models.
Not investment advice.